Literature DB >> 10448364

Do the factors associated with successful contact tracing of patients with gonorrhoea and Chlamydia differ?

J D Ross1, A Sukthankar, K W Radcliffe, J Andre.   

Abstract

OBJECTIVE: To assess and compare factors which may be associated with successful contact tracing in patients with gonorrhoea and chlamydia. STUDY
DESIGN: Prospective observational study of patients attending a genitourinary medicine clinic with a diagnosis of gonorrhoea or chlamydia. Multivariate analysis model including demographic, socioeconomic, and behavioural variables.
RESULTS: The attendance of at least one sexual contact was associated with naming more contacts for patients with gonorrhoea (OR 1.44, 95% CI 1.04-2.01). A history of gonorrhoea was associated with successful contact tracing for patients with chlamydia (OR 1.46, 95% CI 1.12-1.9). Successful contact tracing, as defined by at least one confirmed contact attendance after the index case, was not associated with age, sex, sexual orientation, history of chlamydia, use of condoms, marital status, ethnicity, or socioeconomic status for either gonorrhoea or chlamydia.
CONCLUSIONS: Differences in the composition of the core groups infected with gonorrhoea and chlamydia are not explained by differences in contact tracing success. In the clinic setting studied, the outcome of contact tracing was not associated with a variety of demographic, socioeconomic, and behaviour factors.

Entities:  

Mesh:

Year:  1999        PMID: 10448364      PMCID: PMC1758194          DOI: 10.1136/sti.75.2.112

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  9 in total

1.  Dynamics and control of the transmission of gonorrhea.

Authors:  J A Yorke; H W Hethcote; A Nold
Journal:  Sex Transm Dis       Date:  1978 Apr-Jun       Impact factor: 2.830

2.  Evaluation of field follow-up in a sexually transmitted disease clinic for patients at risk for infection with Neisseria gonorrhoeae and Chlamydia trachomatis.

Authors:  B P Katz; V A Caine; R B Jones
Journal:  Sex Transm Dis       Date:  1992 Mar-Apr       Impact factor: 2.830

3.  New cases seen at genitourinary medicine clinics: England 1997.

Authors:  G Hughes; I Simms; P A Rogers; A V Swan; M Catchpole
Journal:  Commun Dis Rep CDR Suppl       Date:  1998-12

Review 4.  The role and effectiveness of partner notification in STD control: a review.

Authors:  F M Cowan; R French; A M Johnson
Journal:  Genitourin Med       Date:  1996-08

5.  Gonorrhoea in Coventry 1991-1994: epidemiology, coinfection and evaluation of partner notification in the STD clinic.

Authors:  L M David; A A Wade; D Natin; K W Radcliffe
Journal:  Int J STD AIDS       Date:  1997-05       Impact factor: 1.359

6.  Audit of contact tracing for gonococcal and chlamydial infection.

Authors:  K McLean
Journal:  Int J STD AIDS       Date:  1993 May-Jun       Impact factor: 1.359

7.  Epidemiologic differences between chlamydia and gonorrhea.

Authors:  H L Zimmerman; J J Potterat; R L Dukes; J B Muth; H P Zimmerman; J S Fogle; C I Pratts
Journal:  Am J Public Health       Date:  1990-11       Impact factor: 9.308

8.  Repeated gonorrhea: an analysis of importance and risk factors.

Authors:  G F Brooks; W W Darrow; J A Day
Journal:  J Infect Dis       Date:  1978-02       Impact factor: 5.226

9.  The risk of transmission of genital Chlamydia trachomatis infection is less than that of genital Neisseria gonorrhoeae infection.

Authors:  E Lycke; G B Löwhagen; G Hallhagen; G Johannisson; K Ramstedt
Journal:  Sex Transm Dis       Date:  1980 Jan-Mar       Impact factor: 2.830

  9 in total
  2 in total

Review 1.  Developing national outcome standards for the management of gonorrhoea and genital chlamydia in genitourinary medicine clinics.

Authors:  N Low; J Welch; K Radcliffe
Journal:  Sex Transm Infect       Date:  2004-06       Impact factor: 3.519

2.  Reducing the risk of gonorrhoea in black Caribbean men: can we identify risk factors?

Authors:  J D C Ross; A Tariq; M Ghanem; G Gilleran
Journal:  Sex Transm Infect       Date:  2003-04       Impact factor: 3.519

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.